Glyco- and Fc engineering of IgA antibodies for cancer immunotherapy improved 
pharmacokinetics & myeloid effector cell engagement

Kretschmer, A.; Lohse, S.; Meyer, S.; Meulenbroek, L.A.P.M.; Jansen, J.H.M.; Möginger, U.; Sondermann, P.; Kolarich, D.; Leusen, J.H.W.; Valerius, T.

doi:10.1159/000449050

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

会議抄録

Glyco- and Fc engineering of IgA antibodies for cancer immunotherapy improved pharmacokinetics & myeloid effector cell engagement

MPS-Authors

/persons/resource/persons121655

Möginger, U.
Daniel Kolarich, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121498

Kolarich, D.
Daniel Kolarich, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Kretschmer, A., Lohse, S., Meyer, S., Meulenbroek, L., Jansen, J., Möginger, U., Sondermann, P., Kolarich, D., Leusen, J., & Valerius, T. (2016). Glyco- and Fc engineering of IgA antibodies for cancer immunotherapy improved pharmacokinetics & myeloid effector cell engagement. Oncology Research and Treatment, 39(Suppl. 3):, 83-84.

引用: https://hdl.handle.net/11858/00-001M-0000-002C-0994-7

要旨

要旨はありません